Literature DB >> 17043344

Treatment for bacterial overgrowth in the irritable bowel syndrome.

Douglas A Drossman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17043344     DOI： 10.7326/0003-4819-145-8-200610170-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora?

Authors:  Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

Authors:  Brennan M R Spiegel; William D Chey; Lin Chang
Journal:  Am J Gastroenterol       Date:  2008-12       Impact factor: 10.864

Review 3.  Novel therapeutic approaches in IBS.

Authors:  Sylvie Bradesi; Emeran A Mayer
Journal:  Curr Opin Pharmacol       Date:  2007-11-19       Impact factor: 5.547

4.  Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress.

Authors:  M Grover; M Kanazawa; O S Palsson; D K Chitkara; L M Gangarosa; D A Drossman; W E Whitehead
Journal:  Neurogastroenterol Motil       Date:  2008-05-09       Impact factor: 3.598

5.  Intestinal microbiota in functional bowel disorders: a Rome foundation report.

Authors:  Magnus Simrén; Giovanni Barbara; Harry J Flint; Brennan M R Spiegel; Robin C Spiller; Stephen Vanner; Elena F Verdu; Peter J Whorwell; Erwin G Zoetendal
Journal:  Gut       Date:  2012-06-22       Impact factor: 23.059

6.  Targeted therapies for diarrhea-predominant irritable bowel syndrome.

Authors:  Kevin W Olden
Journal:  Clin Exp Gastroenterol       Date:  2012-05-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.